A research team from National Tsing Hua University has discovered that isorhoifolin, a compound derived from the Monstera epipremnoides plant, shows promise in treating traumatic brain injuries. Published in the journal Phytomedicine, the study indicates that the substance facilitates nerve cell regeneration and mitigates harmful substances within astrocytes in mice. The eight-year project involved screening thousands of plant extracts to find a viable solution for neural repair. Lead researcher Linyi Chen noted that the compound can be administered intranasally, potentially offering a noninvasive treatment option. While the findings are significant, the team emphasizes that further toxicology testing and large-scale production are required before clinical trials can commence. This discovery could eventually lead to new therapies for various neurological conditions, including strokes and post-COVID-19 cognitive issues, addressing a global need for effective brain injury treatments.
Source : Focus Taiwan
